Effect of a Three-Tier Prescription Copay on Pharmaceutical and Other Medical Utilization

BACKGROUND: In response to rising prescription drug costs, plan sponsors are increasingly implementing three-tiered pharmacy benefits. OBJECTIVE: This study examined the effect of a three-tiered pharmacy benefit on pharmaceutical utilization and expenditures, medication continuation, and use of other medical resources in a population of continuously eligible, commercially insured enrollees of a preferred provider organization (PPO). RESEARCH DESIGN: A quasi-experimental prepost with comparison group design was used. The pre- and postperiods were each 12 months long. SUBJECTS: The intervention group included enrollees whose employer moved from the PPO's two-tier benefit to a three-tier benefit (n = 6881). The comparison group included enrollees whose employer remained under the PPO's two-tier benefit (n = 13,279). MEASURES: Key dependent variables included total prescription claims and costs, net costs (total minus copay), medication continuation, office visits, and inpatient and emergency room use. RESULTS: Relative to the comparison group, the intervention group experienced lower prescription utilization and expenditures and reduced net costs. Medication continuation rates were lower at 6 and 11 months in one of four chronic therapy classes examined; however, discontinuation could not be clearly linked to tier-three medication use. No significant differences in physician office visits, inpatient, or emergency room use rates were found. CONCLUSIONS: Three-tier prescription copays can control drug costs without evidence of change in use of other medical resources in the year following implementation. Future research should examine a variety of three-tier designs

Business · Capitation · Continuation · Discontinuation · Family medicine · Health care · Intervention (counseling) · Managed care · Medical emergency · Medical prescription · Payment · Prescription drug · Tier 2 network · Utilization management · Antibiotic Use and Resistance · Finance · Medication Adherence and Compliance · Medicine · Nursing · Pharmaceutical Practices and Patient Outcomes · Pharmacy

• The seed of abundance and misery

  Open Access•Linda Twrdek, Kerstin Manzel•Economics & Human Biology•2010

  Incluir item

• A Copayment Increase for Prescription Drugs

  Open Access•Teresa B Gibson, CATHERINE G MCLAUGHLIN et al.•INQUIRY The Journal of Health…•2005

  Incluir item

• Prescription Drug Cost Sharing

  Dana P Goldman, Geoffrey F Joyce et al.•JAMA•2007

  Incluir item

• What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries

  Open Access•Marin Gemmill, Marin C Gemmill et al.•International Journal for Equity…•2008

  Incluir item

• The Effect of Increased Travel Reimbursement Rates on Health Care Utilization in the VA

  Open Access•Richard E Nelson, Bret Hicken et al.•The Journal of Rural Health•2012

  Incluir item

• Cost-Sharing

  John Hsu, Mary Reed et al.•Medical Care•2004

  Incluir item

• Effect of Increased Cost-Sharing on Oral Hypoglycemic Use in Five Managed Care Organizations

  Douglas W Roblin, Richard Platt et al.•Medical Care•2005

  Incluir item

• Effect of Increased Copayments on Pharmacy Use in the Department of Veterans Affairs

  Kevin T Stroupe, Bridget Smith et al.•Medical Care•2007

  Incluir item

• Effect of Tiered Prescription Copayments on the Use of Preferred Brand Medications

  Thomas S Rector, Michael D Finch et al.•Medical Care•2003

  Incluir item

• Outcomes Research Priorities in Chronic Care

  Patricia R Salber, Patricia Salber•Medical Care•2004

  Incluir item

• The Quality of Pharmacologic Care for Adults in the United States

  William H Shrank, Steven M Asch et al.•Medical Care•2006

  Incluir item

• Clinically Sensitive Cost-Sharing for Prescription Drugs

  Michael E Chernew, Michael Chernew et al.•Medical Care•2009

  Incluir item

• Formularies, Therapeutics, and Outcomes

  D S Pete Fullerton, DS Fullerton et al.•Medical Care•2004

  Incluir item

• Effects of Prescription Coinsurance and Income-Based Deductibles on Net Health Plan Spending for Older Users of Inhaled Medications

  Colin R Dormuth, Peter Neumann et al.•Medical Care•2009

  Incluir item

• Patient access to health care and medicines across low-income countries

  Open Access•Dru Srivastava, Divya Srivastava et al.•Social Science & Medicine•2015

  Incluir item

• The assessment of refill compliance using pharmacy records

  Open Access•J F Steiner, Allan V Prochazka•Journal of Clinical Epidemiology•1997

  Incluir item

• Methods for Analyzing Health Care Utilization and Costs

  Paula Diehr, David Yanez et al.•Annual Review of Public Health•1999

  Incluir item

• Estimating the Burden of Disease

  Jo Robinson, J Reneé Robinson et al.•Medical Care•1997

  Incluir item

• The Effect of Increased Prescription Drug Cost-Sharing on Medical Care Utilization and Expenses of Elderly Health Maintenance Organization Members

  Richard E Johnson, Michael J Goodman et al.•Medical Care•1997

  Incluir item

• The Effect of a Medicaid Drug Copayment Program on the Utilization and Cost of Prescription Services

  Arthur A Nelson, C Eugene Reeder et al.•Medical Care•1984

  Incluir item

• A Chronic Disease Score with Empirically Derived Weights

  Daniel O Clark, MICHAEL VON KORFF et al.•Medical Care•1995

  Incluir item